Analysis of our results according to tumor positivity of sentinel nodes resulted in no significant difference in the case of three of the four markers studied, including FOXP3, in contrast to some [14,15], but not all [10] other studies on melanoma SLNs (Table 1). The gene discussed is FOXP3; the disease is neoplasm.